Insider · CIK 0001594565

Galer Bradley S.

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001594565

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-06	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+124K sh	—	—	123,818
2022-03-07	ZOGENIX, INC.U Disposition from Tender	EVP & Chief Medical Officer	UDisposition from Tender	−25K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−53.1K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−8,125 sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−28.1K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−28.5K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−60K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−60K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−39K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−30K sh	—	—	0
2022-03-07	ZOGENIX, INC.Restricted Stock UnitsD Disposition to Issuer	EVP & Chief Medical Officer	DDisposition to Issuer	−45.5K sh	—	—	0
2021-08-09	ZOGENIX, INC.Restricted Stock UnitsA Award	EVP & Chief Medical Officer	AAward	+5,000 sh	—	—	5,000
2021-03-26	ZOGENIX, INC.Restricted Stock UnitsA Award	EVP & Chief Medical Officer	AAward	+15K sh	—	—	15,000
2021-03-26	ZOGENIX, INC.Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+30K sh	—	—	30,000
2021-03-15	ZOGENIX, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−569 sh	$20.70	−$11.8K	20,633
2021-03-15	ZOGENIX, INC.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+1,562 sh	—	—	19,609
2021-03-15	ZOGENIX, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−438 sh	$20.70	−$9,066.6	19,171
2021-03-15	ZOGENIX, INC.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+2,031 sh	—	—	21,202
2021-03-15	ZOGENIX, INC.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+1,625 sh	—	—	22,258
2021-03-15	ZOGENIX, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−455 sh	$20.70	−$9,418.5	21,803
2021-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−1,562 sh	—	—	1,562
2021-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−2,031 sh	—	—	4,062
2021-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−1,625 sh	—	—	4,875
2020-06-25	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	0
2020-06-25	ZOGENIX, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−2,813 sh	$28.12	−$79.1K	17,202
2020-06-25	ZOGENIX, INC.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+10K sh	—	—	20,015
2020-03-18	ZOGENIX, INC.P Purchase	EVP & Chief Medical Officer	PPurchase	+1,000 sh	$19.68	+$19.7K	10,015
2020-03-15	ZOGENIX, INC.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+2,032 sh	—	—	9,573
2020-03-15	ZOGENIX, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−429 sh	$22.01	−$9,442.29	7,541
2020-03-15	ZOGENIX, INC.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+1,563 sh	—	—	7,970
2020-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−2,032 sh	—	—	6,093
2020-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−1,563 sh	—	—	3,124
2020-03-15	ZOGENIX, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−558 sh	$22.01	−$12.3K	9,015
2020-03-04	ZOGENIX, INC.Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+39K sh	—	—	39,000
2020-03-04	ZOGENIX, INC.Restricted Stock UnitsA Award	EVP & Chief Medical Officer	AAward	+6,500 sh	—	—	6,500
2019-03-22	ZOGENIX, INC.Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+63.8K sh	—	—	63,750
2019-03-22	ZOGENIX, INC.Restricted Stock UnitsA Award	EVP & Chief Medical Officer	AAward	+8,125 sh	—	—	8,125
2019-03-15	ZOGENIX, INC.F Tax Payment	EVP & Chief Medical Officer	FTax Payment	−429 sh	$51.88	−$22.3K	5,783
2019-03-15	ZOGENIX, INC.Restricted Stock UnitsM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−1,563 sh	—	—	4,687
2019-03-15	ZOGENIX, INC.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+1,563 sh	—	—	6,212
2018-03-15	ZOGENIX, INC.Restricted Stock UnitsA Award	EVP & Chief Medical Officer	AAward	+6,250 sh	—	—	6,250
2018-03-15	ZOGENIX, INC.Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+37.5K sh	—	—	37,500
2017-12-13	ZOGENIX, INC.P Purchase	EVP & Chief Medical Officer	PPurchase	+1,346 sh	$36.59	+$49.2K	4,033
2017-03-14	ZOGENIX, INC.Restricted Stock UnitsA Award	EVP & Chief Medical Officer	AAward	+10K sh	—	—	10,000
2017-03-14	ZOGENIX, INC.Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+60K sh	—	—	60,000
2016-03-14	ZOGENIX, INC.Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+60K sh	—	—	60,000
2015-10-05	ZOGENIX, INC.Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+30K sh	—	—	30,000
2015-03-17	ZOGENIX, INC.Right to buyA Award	EVP & Chief Medical Officer	AAward	+225K sh	—	—	225,000
2013-12-17	ZOGENIX, INC.Right to buy common stockA Award	EVP & Chief Medical Officer	AAward	+425K sh	—	—	425,000

Recent filings

Accepted (ET)
Jun 104
Galer Bradley S.0000950170-24-071541
SEC(opens sec.gov)
Mar 94
Galer Bradley S.0000899243-22-010297
SEC(opens sec.gov)
Aug 114
Galer Bradley S.0001375151-21-000087
SEC(opens sec.gov)
Mar 304
Galer Bradley S.0001375151-21-000041
SEC(opens sec.gov)
Mar 174
Galer Bradley S.0001375151-21-000023
SEC(opens sec.gov)

Companies

Address

12400 HIGH BLUFF DRIVE, SUITE 650

SAN DIEGO, CA, 92130